COMMUNIQUÉS West-GlobeNewswire

-
CB2 Insights Announces Ticker Symbol Change on OTCQB
17/05/2019 -
Immutep Announces Data from Ongoing TACTI-mel Phase I Clinical Trial in Unresectable or Metastatic Melanoma
17/05/2019 -
Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
17/05/2019 -
AMAG Pharmaceuticals to Host Analyst Day on May 22, 2019 in New York
17/05/2019 -
Emerald Health Therapeutics lance l'huile de CBD de première qualité SYNC 25 sur le marché récréatif de la Colombie-Britannique
17/05/2019 -
Emerald Health Therapeutics Introduces Unique Premium CBD Oil SYNC 25 to British Columbia Recreational Marketplace
17/05/2019 -
Agile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Low-Dose Contraceptive Patch, Twirla®
17/05/2019 -
ADMA Biologics Announces Pricing of Public Offering of Common Stock
17/05/2019 -
Natus to Present at William Blair 39th Annual Growth Stock Conference
17/05/2019 -
Achillion Reports Positive Interim Data for ACH-4471 Phase 2 Combination Trial with Eculizumab at The New Era of Aplastic Anemia and PNH Meeting
17/05/2019 -
Pulmocide presents clinical update from promising antifungal program at 2019 Respiratory Innovation Summit
17/05/2019 -
Arch Biopartners Arranges Convertible Note Financing
17/05/2019 -
Mesoblast to Present at 2019 RBC Capital Markets Global Healthcare Conference
17/05/2019 -
Terveystalo's network of occupational health services to expand: Terveystalo to acquire Työsyke Oy in Kanta-Häme
17/05/2019 -
Biocartis Group NV: Disclosure of a transparency notification
17/05/2019 -
Curetis Announces Financial Results for the First Three Months of 2019
17/05/2019 -
Ascent Industries Provides Update on the Filing of Its Annual Financial Statements, Special Meeting of Shareholders and Annual General Meeting
17/05/2019 -
Avricore Health Provides Update on Status of Management Cease Trade Order
16/05/2019 -
Publication in blood® Highlights Potential for GM-CSF Neutralization as a Solution for CAR-T Induced Neurotoxicity
16/05/2019
Pages